[144] Jazz Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Form 4 filing summary for Taylor Morrison Home Corp. (TMHC): Director Christopher J. Yip reported the acquisition of 387 deferred stock units (DSUs) on 06/30/2025. Each DSU is economically equivalent to one share of TMHC common stock and was received under the company’s Non-Employee Director Deferred Compensation Plan as an election to defer cash retainer and committee fees. The transaction is coded “A,” signifying an award and not an open-market purchase.

After the transaction, Yip’s aggregate holding stands at 14,664 DSUs. The units will settle in common shares upon the earlier of (i) 01-Sep-2027, (ii) the director’s separation from the board, or (iii) a change of control. No common-stock sales or purchases were reported, and no cash price was involved.

The award is relatively small in size and routine in nature, providing limited insights into the company’s near-term fundamentals or insider sentiment beyond ongoing board-level equity alignment.

Insights

Securities Analyst

TL;DR: Routine director DSU award; negligible financial impact, neutral signal.

This Form 4 discloses that Director Christopher Yip added 387 DSUs—about 0.002 % of TMHC’s ~119 million basic shares outstanding—via deferred compensation. The grant increases his total deferred equity to 14,664 units, reinforcing long-term alignment but lacking material size to influence valuation or liquidity. Because the DSUs vest automatically on separation or 09/01/2027, the award neither alters cash flow nor indicates an active bullish stance through open-market buying. In my view, the filing is neutral for investors and does not change the core investment thesis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Merrill Lynch 3075B Hansen Way 1st Floor Palo Alto CA 94043	1000	107630.00	61632841	07/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/05/2020	Equity Compensation	Jazz Pharmaceuticals Plc			1000	03/05/2020	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bruce C Cozadd FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 D04 E5W7	common	06/02/2025	1000	108950.00
Bruce C Cozadd FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD Dublin L2 D04 E5W7	common	05/02/2025	500	60000.00
Bruce C Cozadd FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD Dublin L2 D04 E5W7	common	05/01/2025	1000	116350.00
Bruce C Cozadd FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD Dublin L2 D04 E5W7	common	04/01/2025	1500	185625.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares did TMHC director Christopher Yip acquire?

He acquired 387 deferred stock units, each convertible into one common share.

What is the total TMHC equity holding of Christopher Yip after the transaction?

His aggregate holding rose to 14,664 deferred stock units.

Was the transaction an open-market purchase of TMHC stock?

No. The DSUs were granted under the Non-Employee Director Deferred Compensation Plan and involve no cash purchase.

When will the deferred stock units convert into TMHC common shares?

They convert upon the earliest of September 1, 2027, Yip’s board departure, or a change in control.

Does the filing indicate positive or negative insider sentiment toward TMHC?

The transaction is routine compensation and neutral; it does not strongly signal bullish or bearish sentiment.